|
meta-analysis |
4 |
|
adult |
3 |
|
asian continental ancestry group - genetics |
3 |
|
asians |
3 |
|
diabetes mellitus, type 2 - genetics |
3 |
|
ethyl chloroformate |
3 |
|
female |
3 |
|
fto |
3 |
|
genetic association studies |
3 |
|
genetic predisposition to disease |
3 |
|
genotype |
3 |
|
gut microbiota |
3 |
|
humans |
3 |
|
male |
3 |
|
obesity - genetics |
3 |
|
obesity. type 2 diabetes |
3 |
|
polymorphism, single nucleotide |
3 |
|
proteins - genetics |
3 |
|
apoptosis |
2 |
|
atherosclerosis |
2 |
|
bile acid |
2 |
|
biomarker |
2 |
|
bone mineral density |
2 |
|
cardiorespiratory exercise |
2 |
|
chinese medicine |
2 |
|
column liquid chromatography |
2 |
|
covid-19 |
2 |
|
cyp7b1 |
2 |
|
diagnosis |
2 |
|
farnesoid x receptor |
2 |
|
fingerprint analysis |
2 |
|
gc-tofms |
2 |
|
grape powder extract |
2 |
|
hyodeoxycholic acid |
2 |
|
inflammation |
2 |
|
insulin resistance |
2 |
|
metabolite |
2 |
|
metabolite profiling |
2 |
|
metabolomics |
2 |
|
metabonomic profiling |
2 |
|
metagenomics |
2 |
|
multivariate statistical analysis |
2 |
|
nafld |
2 |
|
osteoarthritis |
2 |
|
osteoporosis |
2 |
|
panax |
2 |
|
panax notoginseng |
2 |
|
parabacteroides distasonis |
2 |
|
pparα |
2 |
|
rehabilitation |
2 |
|
saponin |
2 |
|
schizophrenia |
2 |
|
solid-phase extraction |
2 |
|
ultra-performance liquid chromatography |
2 |
|
urine |
2 |
|
1, 2-dimethylhydrazine (dmh) |
1 |
|
1,5-anhydroglucitol |
1 |
|
12α-hydroxylated bile acids |
1 |
|
16s rdna |
1 |
|
18 o labeling method |
1 |
|
18 o stable isotope labeling |
1 |
|
18 o-labeling |
1 |
|
2,3-dihydroxypropyl mercapturic acid |
1 |
|
2-hydroxybutyric acid |
1 |
|
3-monochloropropane-1,2-diol |
1 |
|
4-methylnaphthalen-1-yl-(1-pentylindol-3-yl) methanone |
1 |
|
4e-bp1 |
1 |
|
5-fluorouracil |
1 |
|
5-ht metabolism |
1 |
|
5/6 renal ablation |
1 |
|
7,12-dimethylbenz(a)anthracene |
1 |
|
7α-dehydroxylation |
1 |
|
7α-hydroxy-4-cholesten-3-one (c4) |
1 |
|
aarp diet and health study |
1 |
|
absolute quantification |
1 |
|
absorption enhancer |
1 |
|
acanthaceae |
1 |
|
acetaminophen |
1 |
|
acetic acid |
1 |
|
aconitum carmichaeli var. hwangshanicum |
1 |
|
acrylamide |
1 |
|
actaea asiatica |
1 |
|
acute cold stress |
1 |
|
acute liver injure |
1 |
|
acute myeloid leukemia |
1 |
|
acute oral toxicity |
1 |
|
acute stress |
1 |
|
adap |
1 |
|
adducts |
1 |
|
adenosine a1 receptor |
1 |
|
adipocytes |
1 |
|
adipose lipid metabolism |
1 |
|
adma |
1 |
|
adme |
1 |
|
advanced fibrosis |
1 |
|
adventitious root |
1 |
|
adventitious roots |
1 |
|
aflatoxins |
1 |
|
age |
1 |
|
agent |
1 |
|
aggressive manifestations of breast cancer |
1 |
|
aging |
1 |
|
agonist |
1 |
|
akkermansia muciniphila |
1 |
|
alcohol |
1 |
|
alcohol-induced liver disease |
1 |
|
alcohol-related liver disease |
1 |
|
alcoholic fatty liver |
1 |
|
alcoholic liver disease |
1 |
|
ald |
1 |
|
alda-1 |
1 |
|
aldehyde dehydrogenase 2 |
1 |
|
aldose reductase(ar) |
1 |
|
alignment |
1 |
|
allergic asthma |
1 |
|
alloprevotella rava |
1 |
|
alloxan-induced diabetes |
1 |
|
aloe-emodin |
1 |
|
alternanthera philoxeroides |
1 |
|
alternanthin b |
1 |
|
alternaria arborescens |
1 |
|
alternative pathway |
1 |
|
alzheimer's disease |
1 |
|
american ginseng |
1 |
|
amino acid |
1 |
|
amino acids |
1 |
|
amino bond |
1 |
|
ammonia |
1 |
|
ammonium |
1 |
|
amnestic mild cognitive impairment |
1 |
|
amniotic fluid |
1 |
|
amplified fragment length polymorphisms |
1 |
|
amuc_1100 |
1 |
|
amyloid-β |
1 |
|
analysis |
1 |
|
anencephaly |
1 |
|
anethole |
1 |
|
angiogenesis |
1 |
|
animal diet |
1 |
|
animal protein |
1 |
|
anisaldehyde |
1 |
|
ankylosing spondylitis |
1 |
|
antagonist |
1 |
|
anthranilic acid |
1 |
|
anthraquinones |
1 |
|
anti-inflammatory |
1 |
|
anti-inflammatory effects |
1 |
|
antibiotic |
1 |
|
antibiotics |
1 |
|
anticancer therapy |
1 |
|
antidiabetic activity |
1 |
|
antidiabetic drugs |
1 |
|
antihyperglycemaic activities |
1 |
|
antioxidation and antistress |
1 |
|
antitumor |
1 |
|
antitumor activity |
1 |
|
antitumor immune responses |
1 |
|
antitussive |
1 |
|
anxiety |
1 |
|
aom |
1 |
|
apc mice min/+ |
1 |
|
apical sodium-dependent bile acid transporter |
1 |
|
apri |
1 |
|
aqueous phase |
1 |
|
arctium lappa |
1 |
|
arginine exchange landscape |
1 |
|
arginine metabolism |
1 |
|
aristolochic acid |
1 |
|
arsenic |
1 |
|
as3mt knockout |
1 |
|
asap1 |
1 |
|
asap1-it1 |
1 |
|
aspartate |
1 |
|
aspartic acid |
1 |
|
asthma |
1 |
|
astragalus membranaceus |
1 |
|
astragalus polysaccharides (aps) |
1 |
|
atlas for alzheimer |
1 |
|
atypical antipsychotics |
1 |
|
autophagic death |
1 |
|
autophagy |
1 |
|
autotaxin |
1 |
|
azoxymethane |
1 |
|
baff |
1 |
|
baicalin |
1 |
|
bariatric surgery |
1 |
|
beagle dogs |
1 |
|
behavior |
1 |
|
benign thyroid adenoma |
1 |
|
benzoic acid |
1 |
|
bifidobacterium longum |
1 |
|
bile acid composition |
1 |
|
bile acid metabolome |
1 |
|
bile acids |
1 |
|
bile reflux |
1 |
|
biliary atresia |
1 |
|
bioanalytical methods |
1 |
|
bioavailability |
1 |
|
bioequivalence |
1 |
|
bioinformatics |
1 |
|
biological activity |
1 |
|
biological life support system |
1 |
|
biological samples |
1 |
|
biomarker discovery |
1 |
|
biomarker verification |
1 |
|
biomarkers |
1 |
|
bioreactor |
1 |
|
black tea |
1 |
|
bladder cancer |
1 |
|
blautia producta |
1 |
|
blood |
1 |
|
blood glucose |
1 |
|
bmi |
1 |
|
bone metastasis |
1 |
|
bone turnover markers |
1 |
|
botanical dietary supplements |
1 |
|
botanical-drug interaction |
1 |
|
brain |
1 |
|
brain glucose metabolism |
1 |
|
brain tissue |
1 |
|
branched chain amino acid |
1 |
|
branched-chain amino acid |
1 |
|
branched-chain amino acids |
1 |
|
branched-chain fatty acids |
1 |
|
breast |
1 |
|
breast cancer |
1 |
|
breviscapine |
1 |
|
bronchodilatory |
1 |
|
c-myc |
1 |
|
cac |
1 |
|
caloric restriction |
1 |
|
cancer |
1 |
|
cancer stem cell |
1 |
|
candida albicans |
1 |
|
canonical correlation analysis |
1 |
|
capillary electrochromatography |
1 |
|
capillary electrophoresis |
1 |
|
carbohydrate |
1 |
|
carbohydrate metabolism |
1 |
|
carbon tetrachloride |
1 |
|
carcinogenesis |
1 |
|
carcinogenicity |
1 |
|
cardiometabolic mortality |
1 |
|
cardiometabolic risk |
1 |
|
cardiovascular disease |
1 |
|
carotid inter-adventitial diameter |
1 |
|
carotid intima-media thickness |
1 |
|
cascade metabolites |
1 |
|
catalase |
1 |
|
cataplasma |
1 |
|
catechins |
1 |
|
caulis aristolochiae manshuriensis |
1 |
|
cd31 |
1 |
|
cd44s |
1 |
|
cell and organ culture |
1 |
|
cell death |
1 |
|
cell proliferation |
1 |
|
cell secretome |
1 |
|
cellular apoptosis |
1 |
|
ceramide |
1 |
|
cerebral ischemia injury |
1 |
|
cerebrospinal fluid |
1 |
|
cesarean section |
1 |
|
challenges of nutritional metabolomics, downstream metabolic effects of nutrition |
1 |
|
characterization |
1 |
|
chemical composition |
1 |
|
chemical substance |
1 |
|
chemometrics |
1 |
|
chemotherapy |
1 |
|
chenodeoxycholic acid (cdca) |
1 |
|
chia seed |
1 |
|
child-pugh classification |
1 |
|
chinese baijiu |
1 |
|
chinese herbs |
1 |
|
chinese materia medica |
1 |
|
chinese population |
1 |
|
chloroformates |
1 |
|
chlorogenic acid |
1 |
|
cholelithasis |
1 |
|
cholestasis |
1 |
|
cholesterol |
1 |
|
cholesterol metabolism |
1 |
|
cholic acid (ca) |
1 |
|
choline |
1 |
|
chromatography fingerprint |
1 |
|
chronic ethanol consumption |
1 |
|
chronic exposure |
1 |
|
chronic hepatitis b |
1 |
|
chronic kidney disease |
1 |
|
chronic liver disease |
1 |
|
chronic renal failure |
1 |
|
chronic restraint stress |
1 |
|
chronic stress |
1 |
|
chronic unpredictable mild stress |
1 |
|
cinnamaldehyde |
1 |
|
cinnamon |
1 |
|
circadian rhythm |
1 |
|
cirrhosis |
1 |
|
citrobacter freundii |
1 |
|
classification |
1 |
|
cleavage |
1 |
|
clinical/biomedical analysis |
1 |
|
clomipramine |
1 |
|
clostridium butyricum |
1 |
|
clusterin |
1 |
|
clustering analysis |
1 |
|
coating |
1 |
|
cognitive function |
1 |
|
cohort study |
1 |
|
colon cancer |
1 |
|
colorectal adenoma |
1 |
|
colorectal adenomas |
1 |
|
colorectal cancer |
1 |
|
combination herbal formulae |
1 |
|
combination herbal formulas |
1 |
|
combined formulas |
1 |
|
complementary and alternative medicine (cam) |
1 |
|
complexed theory system of tcm |
1 |
|
complication |
1 |
|
compound identification |
1 |
|
compound quantitation |
1 |
|
computational work flow |
1 |
|
cona |
1 |
|
concanavalin a |
1 |
|
conditioned medium |
1 |
|
confounding effect |
1 |
|
confounding factor |
1 |
|
congenital malformations |
1 |
|
conjugated bile acids |
1 |
|
conjugation |
1 |
|
consensus mass spectra |
1 |
|
continuous positive airway pressure |
1 |
|
cooking oils |
1 |
|
coordination |
1 |
|
corn oil |
1 |
|
correlation analysis |
1 |
|
cortex moutan |
1 |
|
coumarin |
1 |
|
covalent chromatography |
1 |
|
covariation analysis |
1 |
|
crohn's disease |
1 |
|
crystallinity |
1 |
|
crystallography |
1 |
|
csf biomarkers |
1 |
|
curcumin |
1 |
|
cyanuric acid |
1 |
|
cycloartane triterpene glycosides |
1 |
|
cyclophilin d |
1 |
|
cyp3a |
1 |
|
cysteine-containing peptides |
1 |
|
cytokines |
1 |
|
cytotoxicity |
1 |
|
d. vulgaris |
1 |
|
dai population |
1 |
|
daidzein |
1 |
|
daidzein in rat plasma |
1 |
|
data analysis |
1 |
|
data preprocessing |
1 |
|
de novo lipogenesis |
1 |
|
deconvolution |
1 |
|
deep learning |
1 |
|
dencichine |
1 |
|
deoxynivalenol |
1 |
|
depression |
1 |
|
depressive state |
1 |
|
derivatization |
1 |
|
developmental toxicity |
1 |
|
di-n-butyl phthalate |
1 |
|
diabetes |
1 |
|
diabetes mellitus |
1 |
|
diabetes screening |
1 |
|
diabetic complications |
1 |
|
diagnostic markers |
1 |
|
diammonium glycyrrhizinate |
1 |
|
diet |
1 |
|
diet composition |
1 |
|
diet-induced obesity |
1 |
|
diet-quality index (dqi) scores |
1 |
|
dietary exposure |
1 |
|
different metabolites |
1 |
|
dihydroceramide |
1 |
|
diketogulonic acid |
1 |
|
direct orthogonal signal correction |
1 |
|
discriminant analysis |
1 |
|
disease diagnosis |
1 |
|
dissolution rate |
1 |
|
distilled liquor |
1 |
|
diterpene |
1 |
|
dmba |
1 |
|
dna damage |
1 |
|
dna fingerprinting |
1 |
|
dna methylation |
1 |
|
docosahexaenoic acid |
1 |
|
dosage forms |
1 |
|
drug discovery |
1 |
|
drug interactions |
1 |
|
drug metabolism |
1 |
|
drug targets |
1 |
|
drug transporters |
1 |
|
drug-induced cholestasis |
1 |
|
duloxetine |
1 |
|
dysbiosis |
1 |
|
dysmenorrhea |
1 |
|
early diagnosis |
1 |
|
early warning |
1 |
|
ecm1 |
1 |
|
effective constituent |
1 |
|
efficacy |
1 |
|
eicosapentaenoic acid |
1 |
|
electrospray ionisation-mass spectrometry |
1 |
|
electrospray ionization |
1 |
|
electrospray ionization (esi) |
1 |
|
electrospray ionization mass spectrometry |
1 |
|
ellagic acid |
1 |
|
elovl6 |
1 |
|
emodin |
1 |
|
emotional reactivity |
1 |
|
enantiomers |
1 |
|
endocrine resistance |
1 |
|
endocrine system |
1 |
|
endothelium |
1 |
|
endotoxemia |
1 |
|
energy |
1 |
|
energy expenditure |
1 |
|
energy metabolism |
1 |
|
enrichment |
1 |
|
enterochromaffin cells |
1 |
|
enterohepatic recirculation |
1 |
|
ephedra sinica |
1 |
|
epicatechin |
1 |
|
epididymis |
1 |
|
epigallocatechin gallate |
1 |
|
erk1/2 |
1 |
|
erα |
1 |
|
esophageal cancer |
1 |
|
estrogen receptor |
1 |
|
ethanol intervention |
1 |
|
ethnic |
1 |
|
ethyl chloroformate (ecf) |
1 |
|
eudesmane sesquiterpenes |
1 |
|
eudragit rs100 |
1 |
|
evaluation of therapeutic effects of traditional chinese medicine |
1 |
|
exosome |
1 |
|
experimental autoimmune encephalomyelitis |
1 |
|
experimental inflammatory bowel disease |
1 |
|
exposure |
1 |
|
exposure correlation analysis |
1 |
|
extracted ion chromatogram |
1 |
|
extraction |
1 |
|
fa pathway |
1 |
|
factor analysis |
1 |
|
fam215a |
1 |
|
fanconi anemia (fa) |
1 |
|
farnesoid x receptor (fxr) |
1 |
|
farnesol x receptor (fxr) |
1 |
|
fas |
1 |
|
fasting |
1 |
|
fatty acid desaturase |
1 |
|
fatty acid metabolism |
1 |
|
fatty acid oxidation |
1 |
|
fatty acid β-oxidation |
1 |
|
fatty acids |
1 |
|
fatty liver |
1 |
|
favl |
1 |
|
fecal community type |
1 |
|
fecal microbiota transplantation |
1 |
|
fecal samples |
1 |
|
fermentation |
1 |
|
fib-4 |
1 |
|
fiber |
1 |
|
fibrachek |
1 |
|
fibrosis |
1 |
|
fingerprints |
1 |
|
flavone c-glycoside |
1 |
|
flavonoid |
1 |
|
flos carthami |
1 |
|
flow cytometry analyses |
1 |
|
flower buds of p. notoginseng |
1 |
|
fluorescent quantitative pcr |
1 |
|
folate |
1 |
|
folic acid |
1 |
|
food safety |
1 |
|
foot |
1 |
|
formation |
1 |
|
free fatty acid |
1 |
|
free fatty acids |
1 |
|
fritillaria |
1 |
|
fructose |
1 |
|
fructose utilization |
1 |
|
ft1dm |
1 |
|
fulminant type 1 diabetes |
1 |
|
fumonisins |
1 |
|
functional genomics |
1 |
|
functional metabolomics |
1 |
|
functional prediction |
1 |
|
fungistatic activity |
1 |
|
furosemide |
1 |
|
fvb/n |
1 |
|
fxr |
1 |
|
g protein-coupled bile acid receptor |
1 |
|
g-protein-coupled bile acid receptor 1 |
1 |
|
ga(iii)-edtmp |
1 |
|
gallium ethylenediaminetetramethylene phosphonate |
1 |
|
gallstone |
1 |
|
gap cultivation |
1 |
|
gas chromatography |
1 |
|
gas chromatography and mass spectrometry |
1 |
|
gas chromatography and mass spectrometry (gc-ms) |
1 |
|
gas chromatography mass spectrometry |
1 |
|
gas chromatography time-of-flight mass spectrometry |
1 |
|
gas chromatography-mass spectrometry |
1 |
|
gas chromatography-mass spectrum |
1 |
|
gas chromatography-time-of-flight mass spectrometry |
1 |
|
gas chromatography/mass spectrometry |
1 |
|
gas chromatography/time-of-fight mass spectrometry |
1 |
|
gas chromatography/time-of-flight mass spectrometry |
1 |
|
gastric cancer |
1 |
|
gastric carcinogenesis |
1 |
|
gastrointestinal (gi) cancers |
1 |
|
gastrointestinal tract |
1 |
|
gc |
1 |
|
gc-ms |
1 |
|
gc-tof ms |
1 |
|
gc/ms |
1 |
|
gc/tof/ms |
1 |
|
gc–ms |
1 |
|
gender |
1 |
|
gene expression |
1 |
|
generalized linear model |
1 |
|
genetic markers |
1 |
|
genetic resource conservation |
1 |
|
genetic variants |
1 |
|
genome-scale metabolic models |
1 |
|
genotoxity |
1 |
|
gentiopicroside |
1 |
|
gi disorders |
1 |
|
ginkgo biloba extract |
1 |
|
ginseng |
1 |
|
ginseng extracts |
1 |
|
ginseng polysaccharide |
1 |
|
ginsenoside |
1 |
|
ginsenosides |
1 |
|
global metabolic profiling |
1 |
|
globalization |
1 |
|
glp-1 |
1 |
|
glucagon-like peptide-1 |
1 |
|
glucocorticoid withdrawal |
1 |
|
glucocorticoid-induced adrenal insufficiency |
1 |
|
glucose |
1 |
|
glucose homeostasis |
1 |
|
glucose tolerance |
1 |
|
glut5 |
1 |
|
glycidamide |
1 |
|
glycidol |
1 |
|
glycolipid metabolism |
1 |
|
glycolysis |
1 |
|
glycolysis and oxidative phosphorylation |
1 |
|
glycopeptides |
1 |
|
glycosylation |
1 |
|
gouty arthritis |
1 |
|
gpbar1 |
1 |
|
grade 2 tumor |
1 |
|
gradient boosting |
1 |
|
grape powder |
1 |
|
green tea |
1 |
|
growth |
1 |
|
gsdme |
1 |
|
guanidination |
1 |
|
gut flora |
1 |
|
gut metabolome |
1 |
|
gut microbial-host co-metabolism |
1 |
|
gut microbial-mammalian co-metabolism |
1 |
|
gut microbiome |
1 |
|
gut microbiota-host co-metabolism |
1 |
|
gut microflora |
1 |
|
gut-liver-brain axis |
1 |
|
han population |
1 |
|
haptoglobin |
1 |
|
hbv |
1 |
|
hcc |
1 |
|
hcv |
1 |
|
health assessment |
1 |
|
heart failure |
1 |
|
heat stress |
1 |
|
hemodialysate |
1 |
|
hemodynamics |
1 |
|
hemoglobin adducts |
1 |
|
hepatic encephalopathy |
1 |
|
hepatic fibrosis |
1 |
|
hepatic steatosis |
1 |
|
hepatic stellate cell |
1 |
|
hepatitis b |
1 |
|
hepatitis c |
1 |
|
hepatocellular carcinoma |
1 |
|
hepatocellular carcinoma cells. |
1 |
|
hepatotoxicity |
1 |
|
herbal extract |
1 |
|
herbal medicine |
1 |
|
herbal medicines |
1 |
|
heterocyclic aromatic amines |
1 |
|
high fat diet |
1 |
|
high mass resolution |
1 |
|
high performance capillary electrophoresis |
1 |
|
high performance liquid chromatography mass spectrometry |
1 |
|
high performance liquid chromatography/mass spectrometry |
1 |
|
high-fat diet |
1 |
|
high-performance liquid chromatography |
1 |
|
highly responsive arginine sensors |
1 |
|
highly responsive lactate sensors |
1 |
|
hip fracture |
1 |
|
histamine |
1 |
|
histidine ammonia-lyase |
1 |
|
hnf4α |
1 |
|
homovanillic acid |
1 |
|
host-gut microbial co-metabolism |
1 |
|
hs-spme-gc-tofms |
1 |
|
human fecal water |
1 |
|
human flora-associated animal model |
1 |
|
human liver proteome |
1 |
|
human milk oligosaccharides |
1 |
|
human plasma |
1 |
|
hydrocortisone |
1 |
|
hyocholic acid |
1 |
|
hyperlipidemic pancreatitis |
1 |
|
hypertension |
1 |
|
hypertriglyceridemia |
1 |
|
hypocholesterolemic effects |
1 |
|
hypoglycemic agents |
1 |
|
hypolipidemic effect |
1 |
|
hypolipidemic effects |
1 |
|
hypothalamus |
1 |
|
hypothesis confirmed, revealing mechanistically based biomarkers |
1 |
|
hypoxia-inducible factor-1 α |
1 |
|
ibd |
1 |
|
ileal juice |
1 |
|
imipramine |
1 |
|
immune factor |
1 |
|
immune regulation |
1 |
|
immune response |
1 |
|
immune system |
1 |
|
immunity |
1 |
|
immunology and microbiology section |
1 |
|
immunosuppression |
1 |
|
immunosuppressive activity |
1 |
|
immunotherapy |
1 |
|
indapamide |
1 |
|
indole-3-butyric acid |
1 |
|
industrialization |
1 |
|
infants |
1 |
|
inflammatory bowel disease |
1 |
|
inflammatory cytokines |
1 |
|
influenza |
1 |
|
inhibition of aldose reductase |
1 |
|
inhibitory rate |
1 |
|
insulin |
1 |
|
insulin secretion |
1 |
|
intact |
1 |
|
integration |
1 |
|
interindividual variability |
1 |
|
interleukin-2 |
1 |
|
internal exposure |
1 |
|
intersubject difference |
1 |
|
interval sleep deprivation |
1 |
|
intervention |
1 |
|
intestinal absorption |
1 |
|
intestinal barrier |
1 |
|
intestinal macrophage |
1 |
|
intestinal microbiota |
1 |
|
intestinal microflora ecology |
1 |
|
intima-media thickness |
1 |
|
invasion |
1 |
|
ion transport |
1 |
|
ionization constant |
1 |
|
irritable bowel syndrome |
1 |
|
irritable bowel syndrome (ibs) |
1 |
|
isoelectric focusing |
1 |
|
isoleucine |
1 |
|
isomers |
1 |
|
ivd kit |
1 |
|
jinfu kang |
1 |
|
jinkui shenqi pill |
1 |
|
jnk |
1 |
|
kalman filter |
1 |
|
kangqianling decoction |
1 |
|
kidney-deficiency |
1 |
|
kushensu injection |
1 |
|
l-tyrosine |
1 |
|
l929 cells |
1 |
|
lactate metabolism |
1 |
|
laggera pterodonta |
1 |
|
lc-ms |
1 |
|
lc-ms/ms |
1 |
|
lc-tofms |
1 |
|
lc-tqms |
1 |
|
lc/esi-ms |
1 |
|
lc–ms |
1 |
|
lean diet |
1 |
|
lectin affinity capture |
1 |
|
lectin affinity chromatography |
1 |
|
leontopodium |
1 |
|
leucine |
1 |
|
lignans |
1 |
|
linc00472 |
1 |
|
linear ion trap fourier transform ion cyclotron resonance mass spectrometry (ltq-fticr-ms) |
1 |
|
lipid lowering effect |
1 |
|
lipid metabolism |
1 |
|
lipid storage disorder |
1 |
|
lipidomics |
1 |
|
lipids |
1 |
|
lipopolysaccharides |
1 |
|
liquid chromatography |
1 |
|
liquid chromatography time-of-flight mass spectrometry |
1 |
|
liquid chromatography-electrospray ionization mass spectrometry/mass spectrometry |
1 |
|
liquid chromatography-mass spectrometry |
1 |
|
liquid chromatography-tandem mass spectrometry |
1 |
|
liveboost |
1 |
|
liver |
1 |
|
liver cancer |
1 |
|
liver carcinogenesis |
1 |
|
liver disease |
1 |
|
liver fibrosis |
1 |
|
liver injury |
1 |
|
liver tissue |
1 |
|
lnc00472 |
1 |
|
lncrna |
1 |
|
logistic regression |
1 |
|
long non-coding rna |
1 |
|
low birth weight |
1 |
|
lower extremity arterial disease |
1 |
|
lpa 3 |
1 |
|
ltq-ft mass spectrometer |
1 |
|
ltq-ft ms |
1 |
|
lyases |
1 |
|
lycium barbarum |
1 |
|
lymphatic absorption |
1 |
|
lysophosphatidic acid |
1 |
|
lysophosphatidylcholine |
1 |
|
machine learning |
1 |
|
macrophage |
1 |
|
macrophages |
1 |
|
magnetic resonance imaging |
1 |
|
major depressive disorder |
1 |
|
malat1 |
1 |
|
manganese |
1 |
|
mapk |
1 |
|
mash |
1 |
|
mass spectrometry |
1 |
|
mass spectrometry in metabolomics, metabolites of high selectivity, sensitivity |
1 |
|
mathematical computation |
1 |
|
matrine |
1 |
|
meat intake |
1 |
|
medicinal plant |
1 |
|
medicinal plant tissue culture |
1 |
|
medicinal plants |
1 |
|
medium chain triglyceride |
1 |
|
melamine |
1 |
|
melanoma |
1 |
|
mercapturic acid adducts |
1 |
|
mesenchymal stem cells |
1 |
|
metabolic disease |
1 |
|
metabolic diseases |
1 |
|
metabolic disorders |
1 |
|
metabolic dysfunction |
1 |
|
metabolic engineering |
1 |
|
metabolic fate |
1 |
|
metabolic fingerprinting |
1 |
|
metabolic fingerprinting, spectroscopic signatures distinguishing groups |
1 |
|
metabolic fingerprints |
1 |
|
metabolic memory |
1 |
|
metabolic pathway |
1 |
|
metabolic phenotyping |
1 |
|
metabolic products |
1 |
|
metabolic profiling |
1 |
|
metabolic signatures |
1 |
|
metabolic syndrome |
1 |
|
metabolic transformation |
1 |
|
metabolism |
1 |
|
metabolite markers |
1 |
|
metabolite profile |
1 |
|
metabolites |
1 |
|
metabolome |
1 |
|
metabolomic profiling |
1 |
|
metabolomic strategy |
1 |
|
metabolomics as a dietary tool, using metabolomic profiling |
1 |
|
metabolomics, analytical and profiling, intersalt, intermap study |
1 |
|
metabolomics, butyrate |
1 |
|
metabolomics, spectroscopic signatures, annotation with metabolites |
1 |
|
metabolomics/metabonomics |
1 |
|
metabonomics |
1 |
|
metabonomicst |
1 |
|
metabotype |
1 |
|
metabotyping |
1 |
|
metahonomics |
1 |
|
metallomics |
1 |
|
metaobonomics |
1 |
|
metastasis |
1 |
|
metformin |
1 |
|
method validation |
1 |
|
methyl (1-(5-fluoropentyl)-1h-indazole-3-carbonyl)-l-valinate |
1 |
|
methyl 2-(1-(4-fluorobenzyl)-1h-indazole-3-carboxamido)-3-methylbutanoate |
1 |
|
methylation |
1 |
|
mice |
1 |
|
microarray |
1 |
|
microbe |
1 |
|
microbe-metabolite interaction |
1 |
|
microbes |
1 |
|
microbial metabolomics |
1 |
|
microbial profile |
1 |
|
microbiome |
1 |
|
microbiota |
1 |
|
microbiota extracellular vesicles |
1 |
|
microbiota-host communications |
1 |
|
microemulsion |
1 |
|
microfold cell |
1 |
|
mild cognitive impairment |
1 |
|
mir-192-5p |
1 |
|
mirna |
1 |
|
mitigation |
1 |
|
mitochondria |
1 |
|
mitochondrial permeability transition pore |
1 |
|
modernization |
1 |
|
modernization of traditional chinese medicine |
1 |
|
molecular epidemiology |
1 |
|
molecular imaging |
1 |
|
morphogenesis |
1 |
|
morphology |
1 |
|
mother |
1 |
|
mouse fibroblast cell |
1 |
|
mouse liver |
1 |
|
mouse model |
1 |
|
mri |
1 |
|
mrm |
1 |
|
ms-based acetyl quantification |
1 |
|
msc therapy |
1 |
|
mtor |
1 |
|
multi-component therapeutics |
1 |
|
multi-criteria assessment |
1 |
|
multicomponent nutraceuticals |
1 |
|
multicomponent spectral analysis |
1 |
|
multiple myeloma |
1 |
|
multiple sclerosis |
1 |
|
multivariate analysis |
1 |
|
multivariate statistics |
1 |
|
mycobiome |
1 |
|
mycotoxins |
1 |
|
mzmine 2 |
1 |
|
n-glycosylation |
1 |
|
n-terminal acetyl labeling |
1 |
|
n-trans-feruloyl 3,5-dimethoxytyramine |
1 |
|
nad biosynthesis |
1 |
|
nash |
1 |
|
native hawaiian |
1 |
|
neonatal hepatitis syndrome |
1 |
|
nephrotoxicity |
1 |
|
nested case-control study |
1 |
|
nested case–control study |
1 |
|
network analysis |
1 |
|
network pharmacology |
1 |
|
neural tube defects |
1 |
|
neurodevel-opment |
1 |
|
neurodevelopment |
1 |
|
neurotoxicity |
1 |
|
nf-kb |
1 |
|
nf-κb |
1 |
|
nfs |
1 |
|
nicotinic acid |
1 |
|
nitrogen-recycling bacteria |
1 |
|
nitrogen-recycling intestinal bacteria |
1 |
|
nmr |
1 |
|
nmr and ms, dominant platforms for metabolomics |
1 |
|
nmr spectroscopy |
1 |
|
non-alcoholic fatty liver disease |
1 |
|
non-alcoholic fatty liver disease (nafld) |
1 |
|
non-alcoholic steatohepatitis |
1 |
|
non-alkaloid |
1 |
|
non-diabetes mellitus |
1 |
|
non-invasive |
1 |
|
non-small-cell lung cancer |
1 |
|
non-specific binding inhibitor |
1 |
|
non-volatile compounds |
1 |
|
nonalcoholic fatty liver disease |
1 |
|
nonalcoholic steatohepatitis |
1 |
|
nontargeted metabolomics |
1 |
|
nordic diet |
1 |
|
norditerpenoid alkaloids |
1 |
|
normal-weight metabolically healthy |
1 |
|
nos1ap |
1 |
|
notoginsenoside |
1 |
|
nuclear magnetic resonance |
1 |
|
nuclear magnetic resonance (nmr) |
1 |
|
nutrients |
1 |
|
nutrigenetics |
1 |
|
nutrition |
1 |
|
nutritional metabolomics |
1 |
|
obesity |
1 |
|
obesity-prone |
1 |
|
obesity-resistant |
1 |
|
obstructive sleep apnea |
1 |
|
obstructive sleep apnoea |
1 |
|
ocimum basilicum |
1 |
|
older patients |
1 |
|
one-carbon metabolism |
1 |
|
opls-da |
1 |
|
oplsda |
1 |
|
optic nerve structural tests |
1 |
|
oral absorption |
1 |
|
oral cancer |
1 |
|
oral leukoplakia |
1 |
|
oral microbiota |
1 |
|
oral squamous cell carcinoma |
1 |
|
organic acid |
1 |
|
origin |
1 |
|
osteoarthritis(oa) |
1 |
|
osteolysis |
1 |
|
osteopenia |
1 |
|
osteosarcoma |
1 |
|
ovarian cancer |
1 |
|
oxidative stereochemistry |
1 |
|
oxidative stress |
1 |
|
oxymatrine |
1 |
|
p-coumaric acid |
1 |
|
p38mapk |
1 |
|
paeonia suffruticosa andrews (ranunculaceae) |
1 |
|
paeonol |
1 |
|
panaxadiol |
1 |
|
panaxatriol |
1 |
|
pancreatic cancer |
1 |
|
papillary thyroid carcinoma |
1 |
|
paraprobiotic |
1 |
|
pasteurized akkermansia muciniphila |
1 |
|
pathogenesis |
1 |
|
pathway analysis |
1 |
|
patient stratification |
1 |
|
pattern |
1 |
|
pattern recognition |
1 |
|
pattern recognize |
1 |
|
pbpk model |
1 |
|
peak picking |
1 |
|
pediatric |
1 |
|
pemt |
1 |
|
peptide |
1 |
|
perchlorate |
1 |
|
percutaneous penetration enhancer |
1 |
|
peripheral blood |
1 |
|
peroxisome proliferator-activated receptor α |
1 |
|
personalised medicine |
1 |
|
personalised nutrition |
1 |
|
personalized medicine |
1 |
|
personalized nutrition |
1 |
|
pesticide residues |
1 |
|
pet |
1 |
|
pharmaco-metabonomics |
1 |
|
pharmacogenetics |
1 |
|
pharmacokinetics |
1 |
|
pharmacological activities |
1 |
|
pharmacology network |
1 |
|
pharmacometabonomics |
1 |
|
phenolic amide |
1 |
|
phenotype |
1 |
|
phenylalanine metabolism |
1 |
|
pheratima |
1 |
|
pheretima |
1 |
|
pheretime aspergilum |
1 |
|
phospholipids |
1 |
|
phosphopeptides |
1 |
|
physiologically based toxicokinetic model |
1 |
|
physiologically-based toxicokinetic model |
1 |
|
phytochemical profiling |
1 |
|
phytochemicals |
1 |
|
pig |
1 |
|
piglet |
1 |
|
placenta |
1 |
|
plant extract |
1 |
|
plant protein |
1 |
|
plasma |
1 |
|
point-of-care clinical screening |
1 |
|
poly-pharmacokinetics |
1 |
|
polycystic kidney disease |
1 |
|
polyethylene glycol |
1 |
|
polynesian |
1 |
|
polyol pathway |
1 |
|
polyphenols |
1 |
|
polysaccharide |
1 |
|
polysaccharides |
1 |
|
population-based study |
1 |
|
porcine bile powder |
1 |
|
poria cocos polysaccharide |
1 |
|
positron emission tomography |
1 |
|
post-operative delirium |
1 |
|
postmenopausal |
1 |
|
postprandial |
1 |
|
potential biomarkers |
1 |
|
precancerous colon; metabonomics |
1 |
|
precursor ion exclusion list |
1 |
|
prediction |
1 |
|
predose metabolic profile |
1 |
|
pregnancy disorders |
1 |
|
pregnane x receptor |
1 |
|
prenatal malnutrition |
1 |
|
pressurized capillary electrochromatography |
1 |
|
pressurized capillary electrochromatography (pcec) |
1 |
|
preventive therapy |
1 |
|
primary biliary cirrhosis |
1 |
|
primary liver tumor |
1 |
|
primary open angle glaucoma |
1 |
|
principal component analysis |
1 |
|
principal component analysis(pca) |
1 |
|
probiotic |
1 |
|
probiotics |
1 |
|
processed meat |
1 |
|
prognosis |
1 |
|
proinflammatory cytokine |
1 |
|
proliferation |
1 |
|
propionate |
1 |
|
propyl chloroformate |
1 |
|
protective effect |
1 |
|
protein intake |
1 |
|
proteome |
1 |
|
proteomics |
1 |
|
pseudo-ternary diagram |
1 |
|
pterodontriol e |
1 |
|
pterodontriol f |
1 |
|
pterodontriols |
1 |
|
pu-erh tea |
1 |
|
pyroptosis |
1 |
|
pyrosequencing |
1 |
|
pyrrole-amino acid adducts |
1 |
|
pyrrolizidine alkaloids-induced liver injury |
1 |
|
qinghai wild dahuang tea |
1 |
|
qsyq |
1 |
|
qsyq (t101) |
1 |
|
quadrupole time-of-flight mass spectrometer (qtofms) |
1 |
|
qualitative and quantitative phosphoproteomics |
1 |
|
quality control |
1 |
|
quantification |
1 |
|
quantitative analysis |
1 |
|
quantitative proteomics |
1 |
|
quechers |
1 |
|
quercetin |
1 |
|
radix astragali |
1 |
|
radix astragali polysaccharide |
1 |
|
radix isatidis |
1 |
|
radix sophorae tonkinensis |
1 |
|
random forest |
1 |
|
randomized controlled trial |
1 |
|
ranunculaceae |
1 |
|
rat |
1 |
|
rat urine |
1 |
|
reactive oxygen species |
1 |
|
real-time monitoring |
1 |
|
receiver operating characteristic |
1 |
|
receiver operating characteristics |
1 |
|
red meat |
1 |
|
regulator of g protein signaling 10 protein (rgs10) |
1 |
|
renal fibrosis |
1 |
|
repaglinide |
1 |
|
reproductive |
1 |
|
rer |
1 |
|
resveratrol |
1 |
|
revealed |
1 |
|
reversed phase high performance liquid chromatography/mass spectrometry |
1 |
|
review |
1 |
|
rheb |
1 |
|
rhein |
1 |
|
rheum |
1 |
|
rheumatoid arthritis |
1 |
|
rhizorna chuanxiong |
1 |
|
ribonucleotide reductase small subunit m2b |
1 |
|
rifampicin |
1 |
|
risk assessment |
1 |
|
risk factor |
1 |
|
risk factors |
1 |
|
roc |
1 |
|
ror-γ |
1 |
|
roseburia intestinalis |
1 |
|
rosiglitazone |
1 |
|
saliva |
1 |
|
saliva determination |
1 |
|
salt-sensitive hypertension |
1 |
|
salvianolic acid b |
1 |
|
salylic acid |
1 |
|
saturated fat |
1 |
|
scap-srebps pathway |
1 |
|
schisandra chinensis |
1 |
|
schisandra sphenanthera |
1 |
|
schisandrol b |
1 |
|
scutellaria baicalensis georgi |
1 |
|
secondary metabolites |
1 |
|
selenium |
1 |
|
selenocysteine |
1 |
|
self-microemulsifying drug delivery system |
1 |
|
sepsis |
1 |
|
sequencing platform |
1 |
|
serological diagnosis |
1 |
|
serotonin |
1 |
|
sertraline |
1 |
|
serum |
1 |
|
serum bile acids |
1 |
|
serum biomarkers |
1 |
|
serum metabolites |
1 |
|
serum metabolome |
1 |
|
serum preparation method |
1 |
|
sesquiterpene alkaloid |
1 |
|
sex |
1 |
|
sex difference |
1 |
|
sh3 domain |
1 |
|
short chain fatty acid |
1 |
|
short-chain fatty acids |
1 |
|
short-circuit current |
1 |
|
short-term internal exposure |
1 |
|
shr |
1 |
|
silymarin |
1 |
|
silymarin dripping pills |
1 |
|
silymarin dropping pill |
1 |
|
simultaneous determination |
1 |
|
simvastatin |
1 |
|
site-specific |
1 |
|
slc2a5 |
1 |
|
slow-release formulations |
1 |
|
small intestinal tissues |
1 |
|
small non-coding rnas |
1 |
|
small-molecule metabolite |
1 |
|
software |
1 |
|
solid dispersion |
1 |
|
spa |
1 |
|
spaceflight technology |
1 |
|
spectral deconvolution |
1 |
|
sperm capacitation |
1 |
|
sperm hyperactivation |
1 |
|
sperm motility and transport |
1 |
|
spermine |
1 |
|
spina bifida |
1 |
|
sprague-dawley rats |
1 |
|
st john's wort |
1 |
|
stability |
1 |
|
stable isotope labeling with amino acids in cell culture |
1 |
|
staging |
1 |
|
starch |
1 |
|
steatohepatitis |
1 |
|
steatosis |
1 |
|
stenosis |
1 |
|
stool metabolites |
1 |
|
storage conditions |
1 |
|
storage periods |
1 |
|
stratification |
1 |
|
stress |
1 |
|
structure-retention relationship |
1 |
|
study of the nature of tcm syndromes |
1 |
|
subcellular lactate landscape |
1 |
|
subchronic oral toxicity |
1 |
|
subclinical atherosclerosis |
1 |
|
succinic dehydrogenase |
1 |
|
support vector machine |
1 |
|
surface glycoproteins. |
1 |
|
survival |
1 |
|
synaptic integrity |
1 |
|
synthesis |
1 |
|
synthetic cannabinoids |
1 |
|
syringic acid |
1 |
|
system biology |
1 |
|
systematic difference |
1 |
|
systems biology |
1 |
|
t2dm |
1 |
|
tandem mass spectrometry |
1 |
|
tandem mass spectrometry acquisition |
1 |
|
targeted metabolomics |
1 |
|
targeted panels of metabolites, testing new hypotheses from untargeted approach |
1 |
|
targeting route |
1 |
|
taurine |
1 |
|
tauro-cholic acid |
1 |
|
taurocholic acid |
1 |
|
tcdca/cdca |
1 |
|
tcm |
1 |
|
tcm products |
1 |
|
tea |
1 |
|
technology |
1 |
|
tensino |
1 |
|
teratogenicity |
1 |
|
tgr5 |
1 |
|
the total lignan of fructus arctii (tlfa) |
1 |
|
theabrownin |
1 |
|
thermal stability |
1 |
|
thunbergia |
1 |
|
thunbergia a |
1 |
|
time-of-flight mass spectrometry (tof-ms) |
1 |
|
tio nanoparticle 2 |
1 |
|
tio nanoparticles 2 |
1 |
|
tissue culture |
1 |
|
titanium dioxide |
1 |
|
toll-like receptor 4 |
1 |
|
total mortality |
1 |
|
toxicity |
1 |
|
toxicokinetics |
1 |
|
trace element |
1 |
|
trace element profiling |
1 |
|
trace elements |
1 |
|
traditional chinese drugs |
1 |
|
traditional chinese medicine |
1 |
|
traditional chinese medicine (tcm) |
1 |
|
traditional chinese medicine syndrome |
1 |
|
traditional chinese medicines (tcms) |
1 |
|
traditional chinese prescription |
1 |
|
transcription factor |
1 |
|
transcriptional regulatory networks |
1 |
|
transcriptome |
1 |
|
transcriptomics |
1 |
|
transcriptomics; metabolomics |
1 |
|
transcytosis |
1 |
|
transglutaminase 2 |
1 |
|
translational medicine |
1 |
|
treatment |
1 |
|
treatment based on syndrome differentiation |
1 |
|
treatment by differentiation of syndrome |
1 |
|
tricarboxylic acid intermediates |
1 |
|
triglycerides |
1 |
|
trimetazidine |
1 |
|
tripterygium wilfordii |
1 |
|
trivalent chromium |
1 |
|
trna-derived small rnas |
1 |
|
tryptophan hydroxylase 1 |
1 |
|
tumor microenvironment |
1 |
|
two-dimensional gel electrophoresis |
1 |
|
type 2 |
1 |
|
type 2 diabetes |
1 |
|
type 2 diabetes mellitus |
1 |
|
type ii diabetes |
1 |
|
type-2 diabetes mellitus |
1 |
|
ucp1 |
1 |
|
uhplc-q-orbitrap-hrms |
1 |
|
uhplc-qda detector |
1 |
|
ulcerative colitis |
1 |
|
ultra high performance liquid chromatography (uplc) |
1 |
|
ultra performance liquid chromatography and quadruple/time-of-flight mass spectrometry(uplc-qtofms) |
1 |
|
ultra performance liquid chromatography quadrupole time-of-flight mass spectrometry |
1 |
|
ultra performance liquid chromatography-mass spectrometry |
1 |
|
ultra-performance liquid chromatography (uplc) |
1 |
|
ultra-performance liquid chromatography time-of-flight mass spectrometry |
1 |
|
ultra-zoom gel |
1 |
|
ultraperformance liquid chromatography mass spectrometry |
1 |
|
ultraperformance liquid chromatography quadrupole time-of-flight mass spectrometry |
1 |
|
ultraperformance liquid chromatography quadrupole-time of flight mass spectrometry |
1 |
|
ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry |
1 |
|
ultraperformance liquid chromatography/ time-of-flight mass spectrometry |
1 |
|
ultrasonic treatment |
1 |
|
ultrasonication |
1 |
|
unknown metabolites |
1 |
|
unsaturated fatty acids |
1 |
|
untargeted metabolomics |
1 |
|
untargeted metabolomics, seeking new hypotheses on biochemical mechanisms |
1 |
|
uplc-ms |
1 |
|
uplc-ms/ms |
1 |
|
uplc-qqq/ms |
1 |
|
uplc-qtofms |
1 |
|
uplc-tofms |
1 |
|
uplc/qtofms |
1 |
|
uremic retention solutes |
1 |
|
urinary biomarker |
1 |
|
urinary biomarkers |
1 |
|
urinary metabolite profile |
1 |
|
urinary metabolites |
1 |
|
ursodeoxycholic acid |
1 |
|
uv spectrophotometry |
1 |
|
vaginal microbiota transfer |
1 |
|
valine |
1 |
|
vancomycin |
1 |
|
vegan diet |
1 |
|
veronicastrum sibiricum |
1 |
|
very low carbohydrate diet |
1 |
|
vinyl sulfone |
1 |
|
visceral fat |
1 |
|
visual functional tests |
1 |
|
visualization |
1 |
|
vitamin b 12 |
1 |
|
vitronectin |
1 |
|
volatile compounds |
1 |
|
waist circumference |
1 |
|
warburg effect |
1 |
|
wheat germ agglutinin (wga) affinity chromatography |
1 |
|
whole body |
1 |
|
wistar rats |
1 |
|
women |
1 |
|
workflow |
1 |
|
world cancer day |
1 |
|
xenobiotic intervention |
1 |
|
xuan ju |
1 |
|
xylem |
1 |
|
yersinia pestis |
1 |
|
youden index |
1 |
|
zang-xiang theory |
1 |
|
zinc |
1 |
